Bacil Pharma Ltd

524516

Summary

Fair Value Assessment
Overvalued (9% Premium)
Fair ValueQ37.81UncertaintyVery High
Close Price41.31Mar 25, 2025
Market Closed
40.03
Price Down by 1.28 | 3.10 %
Previous Close
41.31
Day Range
39.60 – 42.00
Year Range
14.35 – 62.56
Bid / Ask
Market Cap
235.8 Mil
Volume / Average
2.0 k / 21.2 k
Beta (5-Year)
-0.03
Shares Outstanding
5.89 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Bacil Pharma Ltd is an Indian-based pharmaceutical company operating in a single segment. It is engaged in the manufacturing of pharmaceuticals, medicinal chemicals, and botanical products. The company manufactures, exports, supplies, and retail Anti Anxiety Medicine, Antihistamines, Chemical Compound, Drugs and Herbal Tablets, and Capsules.
Contact
Sir P. M. Road No. 71, Laxmi Building, 4th Floor, Mumbai, MH 400 001
T +91 2222618452
www.bacilpharma.co.in opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
3

Key Metrics

Income Statement (in null, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
Revenue Growth %
Gross Profit
Gross Profit Margin %
Operating Income
Operating Margin %
EBIT
EBIT Margin %
EBITDA
EBITDA Margin %
Net Income
Net Profit Margin %
Basic EPS
0.59 -0.10 -0.17 -6.55 -0.41 -0.54
Diluted EPS
0.59 -0.10 -0.17 -6.55 -0.41 -0.54
Normalized EPS
Total Dividends per Share
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
18.62 13.26 11.27 12.72 40.88 41.05
Total Liabilities
1.72 1.13 0.28 0.47 26.97 27.18
Total Debt
1.64 0.98 0.21 0.33 1.76 1.69
Total Equity
16.89 12.13 10.99 12.24 13.91 13.87
Cash And Cash Equivalents
1.18 0.41 0.29 2.30 0.99 0.43
Working Capital
-0.24 -0.61 2.01 4.54 -23.95 -24.33
Shares Outstanding (Mil)
5.89 5.89
Book Value Per Share
2.06 1.87 2.08 2.36 2.35
Total Debt To Equity
0.10 0.08 0.02 0.03 0.13 0.12
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
0.05 -0.03 -1.47 -40.09 -3.98 -3.78
Cash From Investing Activities
8.49 0.78 -1.16 38.12 5.28 3.87
Cash From Financing Activities
-7.63 -0.63 0.63 3.27 -0.73 -0.56
Capital Expenditures
Free Cash Flow
-0.86 -1.29 -39.14 -3.77 -4.49
Change in Cash
0.90 0.13 -2.01 1.31 0.56 -0.47

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top